1. BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy
   Taylor C. Brown et al, 2018, Journal of the American College of Surgeons CrossRef
2. Association of single nucleotide polymorphism rs2065955 of the filaggrin gene with susceptibility to Epstein-Barr virus-associated gastric carcinoma and EBV-negative gastric carcinoma
   Xiaojing Kuang et al, 2016, Virologica Sinica CrossRef
3. Association between miR-218 rs11134527 polymorphism and risk of selected types of cancer in Asian population: An updated meta-analysis of case-control studies
   Abdolkarim Moazeni-Roodi et al, 2018, Gene CrossRef
4. MiR-218 produces anti-tumor effects on cervical cancer cells in vitro
   Li Zhu et al, 2018, World Journal of Surgical Oncology CrossRef
5. Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells
   Jing Wang et al, 2019, Cancer Cell International CrossRef
6. MetastamiRs in Renal Cell Carcinoma: An Overview of MicroRNA Implicated in Metastatic Kidney Cancer
   Jonathan Xu et al, 2022, Urologic Cancers CrossRef
7. Epigenetics in renal cell cancer: mechanisms and clinical applications
   Sophie C. Joosten et al, 2018, Nature Reviews Urology CrossRef
8. MicroRNA-1301 inhibits migration and invasion of osteosarcoma cells by targeting BCL9
   Lei Wang et al, 2018, Gene CrossRef
9. MicroRNA Profiling in Wilms Tumor: Identification of Potential Biomarkers
   Fabiola Jimena Pérez-Linares et al, 2020, Frontiers in Pediatrics CrossRef
10. Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma
    Francisca Dias et al, 2017, Oncotarget CrossRef
11. Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma
    Yanghao Tai et al, 2024, Frontiers in Endocrinology CrossRef